Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Small Cell Lung Carcinoma × Observation × Clear all

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Endometrial Neoplasms 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Leukemia 2 Colonic Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Smoldering Multiple Myeloma 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Retinoblastoma 1 Peritoneal Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Melanoma 1

Interventions

Carboplatin 15 Etoposide 13 durvalumab 12 atezolizumab 8 Nivolumab 8 pembrolizumab 7 Cisplatin 7 Topotecan 6 Specimen Handling 5 olaparib 4 berzosertib 4 Temozolomide 4 tremelimumab 3 Radiosurgery 3 PM 01183 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Biopsy 3 AMG 757 3 niraparib 2 cabozantinib 2 Platinum 2 Irinotecan 2 Docetaxel 2 veliparib 1 tazemetostat 1 talazoparib 1 palbociclib 1 lenvatinib 1 futibatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008353 2024-12-19

EDUR-BRA

AstraZeneca

Active not recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡